96493 ⎘
Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
Sub-classes:19-NOR C3, 3-DISUBSTITUTED C21-N-PYRAZOLYL STEROIDS AND METHODS OF USE THEREOF
#23-HYDROXY-5-PREGNANE-20-ONE DERIVATIVE AND USE THEREOF
#319-nor C3,3-disubstituted C21-n-pyrazolyl steroids and methods of use thereof
#419-nor C3, 3-disubstituted C21-N-pyrazolyl steroids and methods of use thereof
#519-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereof
#619-nor C3, 3-disubstituted C21-N-pyrazolyl steroids and methods of use thereof
#719-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereof
#819-nor C3, 3-disubstituted C21-N-pyrazolyl steroids and methods of use thereof
#9Androstane and pregnane steroids with potent allosteric gaba receptor chloride ionophore modulating properties
#1019-nor C3, 3-disubstituted C21-N-pyrazolyl steroids and methods of use thereof
#1119-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereof
#12Process for alkynylating 16-substituted-17-keto steroids
#13Androstane and pregnane steroids with potent allosteric GABA receptor chloride ionophore modulating properties
#14Steroids having increased water solubility and resistance against metabolism, and methods for their production
#15Contraceptive agents
#16Steroids having increased water solubility and resistance against metabolism and methods for their production
#17Process for preparing a crystalline form of halobetasol propionate
#18Method of producing tibolone metabolites by fermentation with
#19Method of producing tibolone metabolites by fermentation with
#20Method of producing tibolone metabolites by fermentation with
#21Method of producing tibolone metabolites by fermentation with
#22Androstane and pregnane steroids with potent allosteric GABA receptor chloride ionophore modulating properties
#23Process for preparing a crystalline form of halobetasol propionate
#24Mineralocorticoid Receptor Antagonists
#2521-substituted progesterone derivatives as new antiprogestational agents
#26Alpha-glucosidase inhibitors from fungal hydroxylation of tibolone and hydroxytibolones
#27Tyrosinase enzyme inhibitors from fungal hydroxylation of tibolone
#28Levonorgestrel Crystallization
#29PROCESS FOR PREPARING 17ALPHA-ACETOXY-6-METHYLENEPREGN-4-ENE-3,20-DIONE, MEDROXYPROGESTERONE ACETATE AND MEGESTROL ACETATE
#30Steroids having increased water solubility and resistance against metabolism, and methods for their production
#31Microbiological process for the production of 7-substitued 11-hydroxy steroids, 7,17-substituted 11-halogen steroids, and uses thereof
#32Process for preparing a crystalline form of halobetasol propionate
#33Nitrosated and nitrosylated compounds and compositions and their use for treating respiratory disorders
#34One-pot processes for preparing prednisolone derivatives
#35Novel polymorph form M of mifepristone and process for its preparation
#36Therapeutic agent for ageing macular degeneration
#37Derivative prodrugs of ethinyl estradiol
#3821-substituted progesterone derivatives as new antiprogestational agents
#39Estrogenic compounds as anti-mitotic agents
#40Process for preparing medrogestone
#41Production process for 16-dehydropregnenoneol and its analogs
#42Steroid compounds with anti-tumor activity
#43Novel steroidal antiestrogens and antiandrogens and uses thereof
#44Sterilization of beclomethasone drug particles for pulmonary delivery
#45Method for preparing 17 alpha-acetoxy-11beta-(4-n,n-dimethylaminophenyl)-19-norpregna-4,9-diene-3,20-dione, intermediates thereof, and methods for the preparation of such intermediates
#46Structural modification of 19-norprogesterone I: 17-α-substituted-11-β-substituted-4-aryl and 21-substituted 19-norpregnadienedione as new antiprogestational agents
#4721-substituted progesterone derivatives as new antiprogestational agents
#48Microbiological process for the production of 7-substituted 11-hydroxy steroids, 7,17-substituted 11-Halogen steroids and uses thereof
#49Process for the synthesis of pharmacologically active (z/e)-guggulsterones
#508β-vinyl-11β-(ω-substituted)alkyl-estra-1,3,5(10)-trienes